Synthesis of 4'-Thionucleosides as Antitumor and Antiviral Agents. 2018

Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University.

Many attempts have been made to synthesize structurally novel nucleoside derivatives in order to identify effective compounds for the treatment of tumors and virus-caused disease. At our laboratories, as part of our efforts to synthesize 4'-thionucleosides, we have identified and characterized biologically active nucleosides. During the course of our synthetic study, we developed the Pummerer-type thioglycosylation reaction. As a result, we synthesized a potent antineoplastic nucleoside, 1-(2-deoxy-2-fluoro-β-D-4-thio-arabino-furanosyl)cytosine (4'-thioFAC), and several novel 4'-thionucleosides that possess antiherpes virus activities.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013872 Thionucleosides Nucleosides in which the base moiety is substituted with one or more sulfur atoms.
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
October 2004, Current medicinal chemistry,
Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
February 2008, Journal of enzyme inhibition and medicinal chemistry,
Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
November 2016, European journal of medicinal chemistry,
Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
January 1999, Nucleosides & nucleotides,
Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
August 1996, Journal of medicinal chemistry,
Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
January 2006, Current topics in medicinal chemistry,
Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
April 2001, Journal of medicinal chemistry,
Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
October 2004, Journal of medicinal chemistry,
Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
January 2003, Arzneimittel-Forschung,
Yuichi Yoshimura, and Yukako Saito, and Yoshihiro Natori, and Hideaki Wakamatsu
January 2007, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!